Literature DB >> 7117386

Coronary interactions between nifedipine and adenosine in the intact dog heart.

G Merrill, M Young, S Dorell, L Krieger.   

Abstract

Coronary vascular interactions between adenosine and the calcium entry blocker, nifedipine were studied in the open-chest, blood-perfused dog heart. Adenosine was administered either as a constant intra-coronary infusion or released endogenously during brief occlusions of the left anterior descending (LAD) coronary artery. Nifedipine was administered in therapeutic concentrations as a single i.v. bolus via the femoral vein. Prior to nifedipine treatment, adenosine (1.2 mumol/kg per min) produced a significant (P less than 0.05) 2-3 fold increase in LAD flow. This response was reduced markedly (P less than 0.05) in a dose-dependent manner by nifedipine (6-20 microgram/kg). Following administration of an average dose of 11 microgram/kg nifedipine, adenosine (1.2 mumol/kg per min) failed to elevate LAD flow significantly. Further, reactive hyperemia, produced by releasing a 30-s occlusion of the LAD, was significantly attenuated by these same nifedipine concentrations. The nifedipine-mediated attenuation could be partially overcome by prolonging the period of occlusion (60 s), or by increasing the rate of adenosine infusion. These results could not be accounted for by a nifedipine-mediated alteration of hemodynamics and suggest the possibility of pharmacological competition between adenosine and nifedipine at a vascular smooth muscle receptor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7117386     DOI: 10.1016/0014-2999(82)90343-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Plasma adenosine concentrations during adenosine-induced respiratory stimulation in man.

Authors:  P G Reid; A H Watt; W J Penny; A C Newby; A P Smith; P A Routledge
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Effect of nifedipine on the myocardial and vascular response to myocardial ischemia.

Authors:  D C Homans; E Sublett; X Z Dai; R J Bache
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.